[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kenai Therapeutics\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100601094","phase-1-a-study-to-assess-safety-and-efficacy-of-surgical-implant-of-rndp-001-in-patients-with-idiopathic-parkinsons-disease-100601094",false,"NCT07106021","A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease","A Phase 1b\u002F2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease","Inclusion Criteria:\n\n* Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorders Society Clinical Criteria\n* Age 45 to 75\n* Medically stable to undergo a surgical procedure\n\nExclusion Criteria:\n\n* Known Parkinson's disease gene mutation or variant\n* Previous infusion therapy or surgery for Parkinson's disease\n* History of allergic reaction or intolerance to an immunotherapeutic agent\n* Contraindication to MRI\n* Clinically significant medical conditions likely to interfere with the surgical procedure or study assessments","ALL","45 Years","75 Years",{"count":20,"type":21},12,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE1","PHASE2","This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.",[28,29],"Idiopathic Parkinson´s Disease","Parkinson's Disease",[31],"RNDP-001","RECRUITING","2026-01-22",{"date":35,"type":36},"2026-01-23","ACTUAL",{"date":38,"type":36},"2025-07-17",{"date":40,"type":21},"2031-06",{"name":42,"class":43},"Kenai Therapeutics","INDUSTRY",3,""]